List of directors and their roles and functions
Filed with HKEX · Stock code 2171 · · 1 page · English
Summary by 6ix AI
This filing is a list of directors and their roles for Carsgen Therapeutics Holdings Ltd.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
CARsgen Therapeutics Holdings Ltd. on 6ix
Earlier from CARsgen Therapeutics
- Resignation of non-executive director and non-compliance with rule 3.21 of the listing rules
- Voluntary announcement - first patient dose of CT1190B in china phase i registrational trial
- Interim report 2026
- CARsgen Therapeutics Announces 2026 Interim Results
- CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors
Later from CARsgen Therapeutics
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - first patient dose of CT0596 in china phase i registrational trial
- Voluntary announcement - research results of satri-cel at the ESMO congress 2026
- Voluntary announcement - abstracts of CT1190B and CT071 published at ASH 2026 annual meeting
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow CARsgen Therapeutics into a list and get an email when it puts out news.
Follow CARsgen Therapeutics